Cargando…
Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid ex-vivo T cells expansion protocol for adoptive immunotherapy: A pilot study
INTRODUCTION: The BNT162b2 mRNA-based vaccine has shown high efficacy in preventing COVID-19 infection but there are limited data on the types and persistence of the humoral and T cell responses to such a vaccine. METHODS: Here, we dissect the vaccine-induced humoral and cellular responses in a coho...
Autores principales: | Mestiri, Sarra, Merhi, Maysaloun, Inchakalody, Varghese P., Taib, Nassiba, Smatti, Maria K., Ahmad, Fareed, Raza, Afsheen, Ali, Fatma H., Hydrose, Shereena, Fernandes, Queenie, Ansari, Abdul W., Sahir, Fairooz, Al-Zaidan, Lobna, Jalis, Munir, Ghoul, Mokhtar, Allahverdi, Niloofar, Al Homsi, Mohammed U., Uddin, Shahab, Jeremijenko, Andrew Martin, Nimir, Mai, Abu-Raddad, Laith J., Abid, Fatma Ben, Zaqout, Ahmed, Alfheid, Sameer R., Saqr, Hassan Mohamed Hassan, Omrani, Ali S., Hssain, Ali Ait, Al Maslamani, Muna, Yassine, Hadi M., Dermime, Said |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933868/ https://www.ncbi.nlm.nih.gov/pubmed/36817441 http://dx.doi.org/10.3389/fimmu.2023.1061255 |
Ejemplares similares
-
Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatment: a case report
por: Merhi, Maysaloun, et al.
Publicado: (2020) -
Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy
por: Taib, Nassiba, et al.
Publicado: (2023) -
Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer
por: Raza, Afsheen, et al.
Publicado: (2022) -
Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
por: Fernandes, Queenie, et al.
Publicado: (2022) -
Squamous Cell Carcinomas of the Head and Neck Cancer Response to Programmed Cell Death Protein-1 Targeting and Differential Expression of Immunological Markers: A Case Report
por: Merhi, Maysaloun, et al.
Publicado: (2018)